HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Scott A Erickson Selected Research

A357300

4/2005Methionine aminopeptidase 2 inhibition is an effective treatment strategy for neuroblastoma in preclinical models.
11/2003Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Scott A Erickson Research Topics

Disease

4Neoplasms (Cancer)
03/2009 - 11/2003
2Neuroblastoma
04/2005 - 11/2003
1Carcinoma (Carcinomatosis)
11/2003
1Sarcoma (Soft Tissue Sarcoma)
11/2003

Drug/Important Bio-Agent (IBA)

2Methionine (L-Methionine)FDA Link
06/2006 - 11/2003
2A357300IBA
04/2005 - 11/2003
2O-(Chloroacetylcarbamoyl)fumagillol (TNP 470)IBA
04/2005 - 11/2003
1tyrosine receptor (receptor, tyrosine)IBA
03/2009
1Epidermal Growth Factor (EGF)IBA
03/2009
1Phosphotransferases (Kinase)IBA
03/2009
1Somatomedin Receptors (Somatomedin Receptor)IBA
03/2009
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2005
1Angiogenesis InhibitorsIBA
04/2005
1methionine aminopeptidase 2IBA
04/2005
1EnzymesIBA
11/2003
1Antineoplastic Agents (Antineoplastics)IBA
11/2003
1AminopeptidasesIBA
11/2003

Therapy/Procedure

2Therapeutics
06/2006 - 11/2003